Aptamer Sciences, Inc.: Clinical Trials

1 trial sponsored by Aptamer Sciences, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Aptamer Sciences, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
AST-201 - Neoplasms, Carcinoma, Hepatocellular
Phase 1RecruitingAptamer Sciences, Inc.702025-03-112026-03-27

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Liver Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Simpson-Golabi-Behmel syndrome (1)

Countries

South Korea (1)

Top investigators

David Lee (1)